Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 1893-1898

  Sugie, Satoru ^a   Mukai, Shoichiro ^a   Tsukino, Hiromasa ^a   Toda, Yoshinobu ^b   Yamauchi, Takenori ^a   Nishikata, Ichiro ^a   Kuroda, Yoshiki ^a   Morishita, Kazuhiro ^a   Kamoto, Toshiyuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b TENRI HEALTH CARE UNIVERSITY   (Japan)

Author keywords

Caveolin 1; ELISA; Progression; Prostate cancer

Indexed keywords

CAVEOLIN 1; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CASTRATION RESISTANT PROSTATE CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CAVEOLIN-1; ELISA; PROGRESSION; PROSTATE CANCER;

AGED; BLOTTING, WESTERN; CAVEOLIN 1; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; JAPAN; MALE; NEOPLASM GRADING; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84878167052     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Committee for Establishment of the Guidelines on Screening for Prostate Cancer. Japanese Urological Association: Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010. Int J Urol 17 (10): 830-838, 2010.
2. Shaul PW and Anderson RG: Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275: L843-L851, 1998.
3. Williams TM and Lisanti MP: Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol 288: C494-C506, 2005. (Pubitemid 40229478)
4. Cavallo-Medved D, Mai J, Dosescu J, Sameni M and Sloane BF: Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. J Cell Sci 118: 1493-1503, 2005. (Pubitemid 40585129)
5. Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP and Lisanti MP: Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am J Pathol 162: 2059-2068, 2003. (Pubitemid 36613061)
6. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R and Sers C: Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159: 1635-1643, 2001. (Pubitemid 33062506)
7. Zhang H, Su L, Muller S, Tighiouart M, Xu Z, Zhang X, Shin HJ, Hunt J, Sun SY, Shin DM and Chen ZG: Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 99: 1684-1694, 2008.
8. Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI and Shariat SF: Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 67: 614-622, 2007. (Pubitemid 46685281)
9. Zhang ZB, Cai L, Zheng SG, Xiong Y and Dong JH: Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. Pathol Oncol Res 15: 495-502, 2009.
10. Williams TM and Lisanti MP: Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288: C494-C506, 2005. (Pubitemid 40229478)
11. Tahir SA, Ren CZ, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM and Thompson TC: Development of an immunoassay for serum caveolin-1: A novel biomarker for prostate cancer. Clin Cancer Res 9: 3653-3659, 2003. (Pubitemid 37169231)
12. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J and Thompson TC: Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 4: 1062-1064, 1998. (Pubitemid 28417340)
13. Yang G, Truong LD, Wheeler TM and Thompson TC: Caveolin- 1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 59: 5719-5723, 1999.
14. Li L, Ren C, Yang G, Goltsov AA, Tabata K and Thompson TC: Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells. Mol Cancer Res 7: 1781-1791, 2009.
15. Lee SW, Reimer CL, Oh P, Campbell DB and Schnitzer JE: Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16: 1391-1397, 1998. (Pubitemid 28151846)
16. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC and Mellon JK: Caveolin-1 expression is associated with highgrade bladder cancer. Urology 58: 811-814, 2001.
17. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM and Schneider U: Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158: 833-839, 2001. (Pubitemid 32221776)
18. Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A and Park S: The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis 13(1): 6-11, 2010.
19. Sawada S, Ishikawa C, Tanji H, Nakachi S, Senba M, Okudaira T, Uchihara JN, Taira N, Ohshiro K, Yamada Y, Tanaka Y, Uezato H, Ohshima K, Sasai K, Burgering BM, Duc Dodon M, Fujii M, Sunakawa H and Mori N: Overexpression of caveolin- 1 in adult T-cell leukemia. Blood 115: 2220-2230, 2010.
20. Li L, Ren CH, Tahir SA, Ren C and Thompson TC: Caveolin-1 maintains activated AKT in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol 23: 9389-9404, 2003. (Pubitemid 37499824)
21. Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA and Thompson TC: Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 61: 4386-92, 2001. (Pubitemid 32685764)
22. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD and Thompson TC: Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 61: 3882-3885, 2001. (Pubitemid 32720945)
23. Watanabe M, Yang G, Cao GW, Tahir SA, Naruishi K, Tabata K, Fattah EA, Rajagopalan K, Timme TL, Park S, Kurosaka S, Edamura K, Tanimoto R, Demayo FJ, Goltsov AA and Thompson TC: Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Mol Cancer Res 7: 1446-1455, 2009.
24. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD and Thompson TC: Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 61: 3882-3885, 2001. (Pubitemid 32720945)
25. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT and Thompson TC: Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 4: 1873-1880, 1998. (Pubitemid 28369170)
26. Thompson TC, Timme TL, Li L and Goltsov A: Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer. Apoptosis 4: 233-237, 1999. (Pubitemid 29424486)
27. Mouraviev V, Li LK, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D and Thompson TC: The role of caveolin-1 in androgen insensitive prostate cancer. J Urol 168: 1589-1596, 2002. (Pubitemid 35034195)